Topical kinase inhibitors induce regression of cutaneous squamous cell carcinoma

A Network Meta-Analysis of the Relative Efficacy of Treatments for Actinic Keratosis of the Face or Scalp in Europe

(2014) Stefan Vegter et al.   PLoS One

From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma

(2012) Vladimir Ratushny et al.   JOURNAL OF CLINICAL INVESTIGATION

Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006

(2010) Howard W. Rogers et al.   ARCHIVES OF DERMATOLOGY

The Skin Cancer Chemotherapeutic Agent Ingenol-3-Angelate (PEP005) Is a Substrate for the Epidermal Multidrug Transporter (ABCB1) and Targets Tumor Vasculature

(2010) Luowei Li et al.   CANCER RESEARCH

Actinic keratoses

(2009) Vincent D. Criscione et al.   CANCER

Srcasm Inhibits Fyn-Induced Cutaneous Carcinogenesis with Modulation of Notch1 and p53

(2009) L. Zhao et al.   CANCER RESEARCH

5-Fluorouracil superficial peel for multiple actinic keratoses

(2009) Ediléia Bagatin et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis

(2008) Osman Kose et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Activation of Src-family tyrosine kinases in hyperproliferative epidermal disorders

(2007) Elias E. Ayli et al.   JOURNAL OF CUTANEOUS PATHOLOGY